Peptide Therapy Websites Tout Benefits Nearly 4x More Often Than Safety Details, 100-Page Audit Finds

Main Idea: An MDConsultingNY audit found that peptide therapy websites promote possible benefits much more often than they explain safety, FDA status, or other key risks.

Key Points:

• The review looked at 100 public peptide-therapy pages from 100 provider websites in 25 states.
• Benefit claims appeared on every page, but the four main safety signals were present only 26.5% of the time on average.
• The report says FDA is preparing to review several peptide-related substances and reminds readers that compounded drugs are not FDA-approved.
• MDConsultingNY says practices should use a “Safety SEO” approach that clearly explains sourcing, supervision, risks, and regulatory status before a patient books a visit.